Ausgewählte Studien

Actas Dermosifiliogr. 2023 Feb 2:S0001-7310(23)00082-0. doi: 10.1016/j.ad.2022.12.004. Online ahead of print. NO ABSTRACT PMID:36738778 | DOI:10.1016/j.ad.2022.12.004 Den ganzen Artikel lesen

EudraCT Number: 2021-001447-27 Sponsor Protocol Number: ANB019-301 Start Date*: 2021-12-08 Sponsor Name:AnaptysBio Inc. Full Title: A Phase 3, …Den ganzen Artikel lesen

Objectives: To determine the individual impact of key manifestations of psoriatic arthritis (PsA) on quality of life (QoL), physical function, and …Den ganzen Artikel lesen

Dermatologie (Heidelb). 2023 Jan 31. doi: 10.1007/s00105-023-05107-8. Online ahead of print. ABSTRACT Psoriasis exacerbation may occur in patients with human immunodeficiency virus (HIV). We present the case of a patient with severe psoriasis vulgaris (PASI 34.2) and an initial HIV diagnosis who showed rapid resolution of psoriasis upon initiation of antiretroviral therapy. Antiretroviral therapy is an effective treatment option for HIV-associated psoriasis. Especially in patients with a sudden

Actas Dermosifiliogr. 2023 Jan 28:S0001-7310(23)00056-X. doi: 10.1016/j.ad.2023.01.004. Online ahead of print. ABSTRACT Recent years have seen concerted efforts to understand the relation between psoriasis and metabolic-associated fatty liver disease (MAFLD). Not only is MALFD diagnosed more often in patients with psoriasis, but its clinical course is also more aggressive. A common approach is therefore needed to enable early detection of liver disease coincident with psoriasis. Especially impor

Psoriasis is associated with an increased risk of cardiovascular disease. Despite recommendation that exercise is important for cardiorespiratory …Den ganzen Artikel lesen

REVIEW ARTICLE Corresponding Author R. Bissonnette Innovaderm Research Inc., Montreal, Quebec, Canada Robert Bissonnette, MD, Innovaderm Research, 3530 …Den ganzen Artikel lesen

LETTER TO THE EDITOR Systemic immune-inflammation biomarkers in psoriasis patients under interleukin 17A-inhibitor treatment Corresponding Author T. …Den ganzen Artikel lesen

The European Union Clinical Trials Register allows you to search for protocol and results information on: interventional clinical trials that are …Den ganzen Artikel lesen

Br J Dermatol. 2023 Jan 23;188(1):122-130. doi: 10.1093/bjd/ljac027. ABSTRACT BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory disease that affects intertriginous skin. OBJECTIVES: To determine the extent of work ability and productivity impairment as a result of HS in Germany. METHODS: A prospective, multicentre, epidemiological, noninterventional study of patients with HS was conducted. Medical history, medical examination performed by dermatologists and patient-reported out

Wollina U. Wollina U. Dermatol Ther. 2019 Mar;32(2):e12805. doi: 10.1111/dth.12805. Epub 2018 Dec 27. Dermatol Ther. 2019. PMID: 30565362 …Den ganzen Artikel lesen

Wang Y, Song ZB, Deng XR, Zhang XH, Zhang ZL. Wang Y, et al. Chin Med J (Engl). 2021 Oct 20;134(21):2564-2572. doi: 10.1097/CM9.0000000000001810. …Den ganzen Artikel lesen

Ann Dermatol Venereol. 2023 Jan 16:S0151-9638(22)00122-3. doi: 10.1016/j.annder.2022.11.008. Online ahead of print. ABSTRACT BACKGROUND: While numerous surveys over the last decade have evaluated the burden of skin diseases, none have focused on the specific impact of disease-location on the hands and face. AIM: The purpose of our study was to evaluate the burden of 8 skin diseases on the multidimensional aspects of subjects' daily lives in respect to their location on visible body areas (face o

Original Article|Articles in Press Academic & Personal: 24 hour online access • Corporate R&D Professionals: 24 hour online access Powered ByMendeley • Add …Den ganzen Artikel lesen

Chimalakonda A, Burke J, Cheng L, Catlett I, Tagen M, Zhao Q, Patel A, Shen J, Girgis IG, Banerjee S, Throup J. Chimalakonda A, et al. Dermatol Ther …Den ganzen Artikel lesen

Full text linksCite Display options Display options Objectives: To evaluate the ability of fluorescence-optical imaging (FOI) to detect preclinical …Den ganzen Artikel lesen

Full text linksCite Display options Display options Introduction: Tumour necrosis factor inhibitor (TNFi) agents are most often the first-choice …Den ganzen Artikel lesen

Background: Immune-mediated inflammatory diseases (IMID) can lead to a substantial disease burden for those affected, in particular by the …Den ganzen Artikel lesen

Chang HW, Yan D, Singh R, Liu J, Lu X, Ucmak D, Lee K, Afifi L, Fadrosh D, Leech J, Vasquez KS, Lowe MM, Rosenblum MD, Scharschmidt TC, Lynch SV, …Den ganzen Artikel lesen

Dudics S, Langan D, Meka RR, Venkatesha SH, Berman BM, Che CT, Moudgil KD. Dudics S, et al. Int J Mol Sci. 2018 Aug 24;19(9):2508. doi: …Den ganzen Artikel lesen

Full text linksCite Display options Display options The better understanding of the immunopathogenesis of psoriasis has led to the development of highly …Den ganzen Artikel lesen

Ravelli A, Consolaro A, Schiappapietra B, Martini A. Ravelli A, et al. Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S40-3. Epub 2015 Oct 15. Clin …Den ganzen Artikel lesen

Dermatol Ther (Heidelb). 2023 Jan 13. doi: 10.1007/s13555-022-00881-0. Online ahead of print. ABSTRACT Generalized pustular psoriasis (GPP) is a rare, chronic, and severe inflammatory skin disorder characterized by sudden eruption of sterile pustules, often accompanied by systemic inflammation. GPP flares can be life-threatening if untreated, owing to potential serious complications such as sepsis and cardiovascular failure. Diagnosis and clinical measurement of disease severity in GPP are often

Ophthalmologie. 2023 Jan 12. doi: 10.1007/s00347-022-01793-2. Online ahead of print. ABSTRACT Acute anterior uveitis (AAU) associated with human leukocyte antigen (HLA) B27 is the most common form of noninfectious intraocular inflammation and is considered to be a separate clinical entity. Young adults between the ages of 20 and 40 years are predominantly affected. The HLA-B27 positive AAU typically presents as a unilateral, fulminant disruption of the blood-aqueous humor barrier, which is accom

Reich K, Sullivan J, Arenberger P, Mrowietz U, Jazayeri S, Augustin M, Parneix A, Regnault P, You R, Milutinovic M. Reich K, et al. Br J Dermatol. …Den ganzen Artikel lesen